APP下载

叶酸片联合阿托伐他汀钙片对高同型半胱氨酸血症患者颈总动脉内膜中层厚度影响的长期观察

2017-05-22林晨志黄雅玲

中国医药科学 2017年6期
关键词:同型半胱氨酸

林晨志+黄雅玲

[摘要] 目的 探讨叶酸片联合阿托伐他汀钙片能否对延缓高同型半胱氨酸血症(HCY)患者颈总动脉内膜中层增厚产生协同疗效。 方法 选取高HCY患者90例,随机分为三组,每组30例。联合组给予叶酸片和阿托伐他汀钙片治疗,他汀组给予阿托伐他汀钙片治疗,叶酸组给予叶酸片治疗。观察三组在治疗前后不同时间点上,颈总动脉内膜中层厚度(IMT)、血浆HCY、血总胆固醇(TC)、低密度脂蛋白胆固醇(LDL)、甘油三酯(TG)以及超敏C反应蛋白(hsCRP)的变化情况。 结果 在治疗后的各观察时间点上组间比较,联合组的血浆HCY水平较叶酸组,均无明显降低(P>0.05);联合组的血TC、LDL、TG水平较他汀组,均无统计学意义(P>0.05)。在治疗后24个月观察时间点上组间比较:联合组的IMT小于他汀组(P<0.05),联合组的IMT小于叶酸组(P<0.05)。 结论 叶酸联合阿托伐他汀钙片能明显降低高同型半胱氨酸血症患者血同型半胱氨酸水平和血脂水平,联合治疗减少颈总动脉内膜中层厚度的远期效果更显著,更有利于延缓动脉粥样硬化。

[关键词] 叶酸;阿托伐他汀钙;同型半胱氨酸;颈动脉;中层内膜厚度

[中图分类号] R543.4 [文献标识码] A [文章编号] 2095-0616(2017)06-11-05

[Abstract] Objective To study the synergistic effect of folic acid tablets in combination with atorvastatin calcium tablet to common carotid artery intima-media thickness(CCA-IMT) of patients with hyperhomocysteinemia. Methods 90 patients with high HCY were randomly divided into three groups,30 cases in each group.Patients in joint group were treated with folic acid tablets and atorvastatin calcium,patients in statin group were treated with atorvastatin calcium, patients in folic acid group were treated with folic acid tablets.The common carotid artery intima-media thickness (IMT),plasma HCY,blood total cholesterol(TC),low-density lipoprotein cholesterol (LDL),triglycerides (TG) and hypersensitive c-reactive protein (hsCRP) changes of the three groups at different time points before and after treatment were observed. Results After treatment,the comparison of each observation point was as follows:Compared with the folic acid group,there were no significantly decreased on plasma HCY levels of joint group(P>0.05).Compared with the statin group, there were no significantly decreased on blood TC,LDL,TG level of joint group(P>0.05).24 months after treatment group,comparison between observation time point was as follows:IMT of joint group was less than that of statin group(P<0.05),the IMT of joint group was less than that of folic acid group(P<0.05). Conclusion Folic acid tablets in combination with atorvastatin calcium tablet can obviously reduce homocysteine levels in patients with blood homocysteine levels and blood lipid levels.Combination therapy to reduce the forward of the common carotid artery intima-media thickness effect is more prominent,and it is more conducive to postpone sclerosis of arterial congee appearance.

[Key words] Folic acid;Atorvastatin calcium;Homocysteine;Carotid artery;Middle membrane thickness

隨着社会的发展,缺血性心脏病及脑血管疾病已成为全球的第一、二位的死亡原因,而缺血性心

脏病及脑血管疾病共同的病理基础是动脉粥样硬化。动脉粥样硬化形成的病理生理过程是脂质成分(以胆固醇为主)在动脉壁的沉积。研究显示,血清总胆固醇水平与动脉粥样硬化的发生、发展密切相关[1]。高同型半胱氨酸(HCY)血症可引起血管内皮功能损害[2],其已成为继高血压高血脂糖尿病吸烟肥胖等因素之后,动脉粥样硬化的又一独立危险因子[3]。高胆固醇血症和高同型半胱氨酸血症叠加将加速全身动脉粥样硬化的发生及发展。作为……

登录APP查看全文

猜你喜欢

同型半胱氨酸
联合检测血清同型半胱氨酸、超敏C反应蛋白及D—二聚体对脑梗死的临床价值
HbA1c、Lp—PLA2、Hcy水平与冠心病合并糖尿病患者PCI术后不良事件的相关性研究
临床检验学中急性脑梗死患者的超敏C反应蛋白、同型半胱氨酸及脂蛋白a联合检测变化研究
脂联素、同型半胱氨酸和超敏C—反应蛋白与高血压的关系
原发性高血压患者血清同型半胱氨酸水平与靶器官损害的关系
高血压病患者血浆同型半胱氨酸与血脂关系分析研究
急性脑梗死辨证分型与ADC、Hcy及hs—CRP的相关性研究
短暂性脑缺血发作患者ABCD2评分与血浆同型半胱氨酸水平的关系
二甲双胍治疗糖尿病67例的疗效观察及对同型半胱氨酸及甲基丙二酸水平的影响
阿托伐他汀治疗143例老年H型高血压疗效观察